How did CVS's revenue and expenses trend in Q4 2024?

CVS Health's revenue for Q4 2024 was $173.61 billion, reflecting a significant growth rate of 15.65%. However, the company's operating expenses, research and development expenses, and selling, general, and administrative expenses were not provided in the report. 1. **Revenue Trend**: CVS Health's revenue trend in Q4 2024 was positive, with a substantial increase of 15.65% compared to the previous period. This indicates a strong performance in terms of sales and service delivery. 2. **Expense Information**: The company's operating expenses, research and development expenses, and selling, general, and administrative expenses were not disclosed in the report. This makes it difficult to assess the company's cost structure and profitability for the period. |code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code| |---|---|---|---|---|---|---| |CVS|CVS.N|CVS Health|20240101-2024|Intersegment Eliminations|-5.6412E10|169| |CVS|CVS.N|CVS Health|20240101-2024|Intersegment Eliminations|-4.0547E10|169| |CVS|CVS.N|CVS Health|20240101-2024|Intersegment Eliminations|-2.6285E10|169| |CVS|CVS.N|CVS Health|20240101-2024|Intersegment Eliminations|-1.2924E10|169| |CVS|CVS.N|CVS Health|20240101-2024|Pharmacy & Consumer Wellness|2.8725E10|169| |CVS|CVS.N|CVS Health|20240101-2024|Corporate|1.15E8|169| |CVS|CVS.N|CVS Health|20240101-2024|Health Care Benefits|3.2236E10|169| |CVS|CVS.N|CVS Health|20240101-2024|Health Services|4.0285E10|169| |CVS|CVS.N|CVS Health|20240101-2024|Intersegment Eliminations|-1.2924E10|169| |code|Ticker|Name|Date|Selling, General, and Administrative Expenses|R&D Expenses|Operating Expenses|market_code| |---|---|---|---|---|---|---|---| |CVS|CVS.N|CVS Health|2024 Q1|1.029E10|||169| |CVS|CVS.N|CVS Health|2024 Q2|1.0338E10|||169| |CVS|CVS.N|CVS Health|2024 Q3|1.0557E10|||169| |CVS|CVS.N|CVS Health|2024 Q4|1.0421E10|||169|